Maternal and neonatal outcomes following the introduction of oral hypoglycaemic agents for gestational diabetes mellitus were comparable to insulin monotherapy in two historical cohorts

Veronique NicolaouLarske SoepnelKenneth HuddleN LevittKerstin Klipstein-GrobuschShane Norris2023-06-212023-06-21WOS0256-9574https://hdl.handle.net/10539/35593Maternal and neonatal outcomes following the introduction of oral hypoglycaemic agents for gestational diabetes mellitus were comparable to insulin monotherapy in two historical cohorts